Story perspectives

Hospitals Ignore Risks of Controversial Medtronic Device

11/13/2025

50 5

Summary

Story summary

Freeman Hospital and Harefield Hospital continued using a Medtronic device linked to higher death rates, despite NHS concerns.
The Medtronic device was withdrawn in 2021.
The device showed 49% mortality within three years, versus 19% for the Abbott device.
Patients, including Greg Marshall, a 26-year-old patient, faced severe complications such as cardiac arrest.
His mother criticized the lack of transparency about device risks and the health professional's financial ties.

1 of 1

Story summary

Freeman Hospital and Harefield Hospital continued using a Medtronic device linked to higher death rates, despite NHS concerns.
The Medtronic device was withdrawn in 2021.
The device showed 49% mortality within three years, versus 19% for the Abbott device.
Patients, including Greg Marshall, a 26-year-old patient, faced severe complications such as cardiac arrest.
His mother criticized the lack of transparency about device risks and the health professional's financial ties.